ES2145886T3 - Derivados de 3,3a,4,5-tetrahidro-1h-oxazolo(3,4-a)quinolein-1-ona. - Google Patents

Derivados de 3,3a,4,5-tetrahidro-1h-oxazolo(3,4-a)quinolein-1-ona.

Info

Publication number
ES2145886T3
ES2145886T3 ES95401989T ES95401989T ES2145886T3 ES 2145886 T3 ES2145886 T3 ES 2145886T3 ES 95401989 T ES95401989 T ES 95401989T ES 95401989 T ES95401989 T ES 95401989T ES 2145886 T3 ES2145886 T3 ES 2145886T3
Authority
ES
Spain
Prior art keywords
oxazolo
tetrahidro
quinolein
ona
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95401989T
Other languages
English (en)
Inventor
Samir Jegham
Jean Jacques Koenig
Frederic Puech
Philippe Burnier
Lydia Zard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Application granted granted Critical
Publication of ES2145886T3 publication Critical patent/ES2145886T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Quinoline Compounds (AREA)

Abstract

DERIVADOS DE 3,3A,4,5-TETRAHIDRO-1H-OXAZOLO [3,4-A] QUINOLEIN1-ONA DE FORMULA GENERAL (I) EN LA QUE N ES IGUAL A 0 O 1, R1 REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO ETENILO, METILO, ETILO, FENILO, HIDROXIMETILO O METOXIMETILO, Y BIEN R2 ES UN GRUPO METILO, TRIFLUORMETILO O CIANO, R3 ES UN ATOMO DE HIDROGENO O UN GRUPO HIDROXILO O BENCILOXI Y R4 Y R5 SON ATOMOS DE HIDROGENO, BIENE R2 Y R4 FORMAN JUNTOS UN GRUPO -(CH2)4-, R3 ES UN GRUPO HIDROXILO Y R5 ES UN ATOMOS DE HIDROGENO, NOEMN R2 Y R5 FORMAN JUNTOS UN GRUPO -OCH{DSUB,2)3- Y R3 Y R4 SONM ATOMOS DE HIDROGENO, BIOENE R2 Y R5 FORMAN JUNTOS UN GRUPO .(CH2)4, R3 ES UN GRUPO HIDROXILO Y R4 ES UN ATOMO DE HIDROGENO. APLICACION EN TERAPIA.
ES95401989T 1994-09-05 1995-09-01 Derivados de 3,3a,4,5-tetrahidro-1h-oxazolo(3,4-a)quinolein-1-ona. Expired - Lifetime ES2145886T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9410600A FR2724171B1 (fr) 1994-09-05 1994-09-05 Derives de 3,3a,4,5-tetrahydro-1h-oxazolo(3,4-a)quinolein-1-one, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
ES2145886T3 true ES2145886T3 (es) 2000-07-16

Family

ID=9466686

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95401989T Expired - Lifetime ES2145886T3 (es) 1994-09-05 1995-09-01 Derivados de 3,3a,4,5-tetrahidro-1h-oxazolo(3,4-a)quinolein-1-ona.

Country Status (28)

Country Link
US (1) US5641785A (es)
EP (1) EP0699680B1 (es)
JP (1) JP4225585B2 (es)
KR (1) KR100392523B1 (es)
CN (1) CN1055472C (es)
AT (1) ATE190311T1 (es)
AU (1) AU687591B2 (es)
CA (1) CA2157427C (es)
CZ (1) CZ286128B6 (es)
DE (1) DE69515402T2 (es)
DK (1) DK0699680T3 (es)
ES (1) ES2145886T3 (es)
FI (1) FI110945B (es)
FR (1) FR2724171B1 (es)
GR (1) GR3033554T3 (es)
HK (1) HK1013652A1 (es)
HU (1) HU218587B (es)
IL (1) IL115276A (es)
NO (1) NO306617B1 (es)
NZ (1) NZ272920A (es)
PL (1) PL184412B1 (es)
PT (1) PT699680E (es)
RU (1) RU2141482C1 (es)
SI (1) SI0699680T1 (es)
SK (1) SK281867B6 (es)
TW (1) TW356467B (es)
UA (1) UA41916C2 (es)
ZA (1) ZA957414B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1078632A1 (en) * 1999-08-16 2001-02-28 Sanofi-Synthelabo Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity
WO2005090309A1 (en) * 2004-03-12 2005-09-29 Wyeth 1,2-dihydroquinoline derivatives and method for using the same to treat hiv infection
NZ579431A (en) * 2007-03-09 2012-04-27 Sanofi Aventis Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
RU2366430C2 (ru) 2007-05-23 2009-09-10 Виктор Иванович Рощин Ингибиторы моноаминооксидазы, лекарственное средство и фармацевтическая композиция
AR078171A1 (es) 2009-09-15 2011-10-19 Sanofi Aventis Dihidrobenzocicloalquiloximetil-oxazolopirimidinonas sustituidas, preparacion y uso de las mismas
CN105949120B (zh) * 2016-05-27 2018-07-24 广东工业大学 一种四齿螯合型单喹啉衍生物及其制备方法和作为神经退行性疾病的金属离子调节剂的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2624861B1 (fr) * 1987-12-21 1990-06-01 Delalande Sa Carbamates tricycliques, leur procede de preparation et leur application en therapeutique
ES2013391A6 (es) * 1989-02-08 1990-05-01 Consejo Superior Investigacion Procedimiento para la preparacion de derivados acetilenicos y alenicos de 2-aminometil -5-metoxiindoles.
JPH04295470A (ja) * 1991-03-22 1992-10-20 Wakamoto Pharmaceut Co Ltd モノアミンオキシダーゼ−ｂ酵素阻害活性を有する１，２，４−オキサジアゾール誘導体及びその製造法

Also Published As

Publication number Publication date
ZA957414B (en) 1996-04-15
NO953458L (no) 1996-03-06
SK108995A3 (en) 1996-06-05
ATE190311T1 (de) 2000-03-15
HK1013652A1 (en) 1999-09-03
HU9502578D0 (en) 1995-11-28
KR960010648A (ko) 1996-04-20
HUT73435A (en) 1996-07-29
IL115276A0 (en) 1996-01-19
NO306617B1 (no) 1999-11-29
CA2157427C (en) 2010-06-01
DE69515402T2 (de) 2000-10-19
US5641785A (en) 1997-06-24
SI0699680T1 (en) 2000-10-31
KR100392523B1 (ko) 2003-11-12
CN1128763A (zh) 1996-08-14
EP0699680B1 (fr) 2000-03-08
CZ226295A3 (en) 1996-03-13
CZ286128B6 (cs) 2000-01-12
CN1055472C (zh) 2000-08-16
FI954141A (fi) 1996-03-06
FR2724171A1 (fr) 1996-03-08
GR3033554T3 (en) 2000-09-29
AU3041595A (en) 1996-03-21
PT699680E (pt) 2000-08-31
HU218587B (hu) 2000-10-28
JP4225585B2 (ja) 2009-02-18
PL310273A1 (en) 1996-03-18
NO953458D0 (no) 1995-09-04
TW356467B (en) 1999-04-21
FR2724171B1 (fr) 1997-01-03
DK0699680T3 (da) 2000-08-21
FI110945B (fi) 2003-04-30
IL115276A (en) 1998-12-06
CA2157427A1 (en) 1996-03-06
SK281867B6 (sk) 2001-08-06
EP0699680A1 (fr) 1996-03-06
RU2141482C1 (ru) 1999-11-20
JPH0899881A (ja) 1996-04-16
NZ272920A (en) 1998-03-25
AU687591B2 (en) 1998-02-26
PL184412B1 (pl) 2002-10-31
UA41916C2 (uk) 2001-10-15
FI954141A0 (fi) 1995-09-04
DE69515402D1 (de) 2000-04-13

Similar Documents

Publication Publication Date Title
FI945703A0 (fi) 3,4,4-trisybstituoitujen piperidinyyli-N-alkyylikarboksylaattien ja välituotteiden valmistus
ATE226201T1 (de) Substituierte pyridylpyrazole
MX9102407A (es) 4 arilpiperazinas y 4-arilpiperidinas novedosas.
ES2112029T3 (es) Nuevos filtros solares, composiciones cosmeticas fotoprotectoras que los contienen y utilizaciones.
ES2145886T3 (es) Derivados de 3,3a,4,5-tetrahidro-1h-oxazolo(3,4-a)quinolein-1-ona.
ATE103594T1 (de) Fucosidase-inhibitoren.
DE69033342D1 (de) Etoposidanaloge
DE69606337D1 (de) Trizyklische Derivate, ihre Herstellung, ihre Verwendung zur Herstellung von optisch aktivem oder racemischem Colchizin, Thiocolchizin, dessen Analoge oder Derivate, und Intermediate
FR2716198B1 (fr) Facteur cytotoxique tel qu'associé à la sclérose en plaques, sa détection et sa quantification.
FI930092A0 (fi) Indanopyrrolidinkarbamater
ATE136307T1 (de) Trazodone alkyl derivate mit zns wirkung
FI952203A0 (fi) Sykloheksaanijohdannaiset, menetelmä niiden valmistamiseksi ja yhdisteiden käyttö sairauksien hoitamiseksi
RS50791B (sr) Farmaceutske kombinacije zasnovane na derivatima piridoindolona
ATE265854T1 (de) Azasteroidverbindung zur behandlung oder vorbeugung von prostatakrebs
GB9520092D0 (en) Chemical compounds
ATE127806T1 (de) Antibiotikverbindungen und ihre herstellung.
DE3865521D1 (de) 4-methyl-4-phenyl-1-pentanale, deren herstellung und verwendung als riechstoffe.
ITMI912104A1 (it) Poliglucosidi da idrossialchilsorbitolo
FI902272A0 (fi) Foerfarande foer isolering och vidarerening av plasmaproteinerna ttr och rbp.
ECSP900699A (es) Nuevas fluro- naftacenodionas, sus derivados glicosilatados y sus procedimientos de fabricacion

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 699680

Country of ref document: ES